Skip to main content

Use of Dermoscopy to Diagnose and Select BCCs that can be Treated Empirically

Abstract

Purpose of Review

The diagnostic value of dermoscopy for basal cell carcinomas (BCCs) is well established. This paper aims to review available data on the role of dermoscopy not only in the management of BCCs in everyday practice and mainly in selecting tumors that may be treated non-surgically.

Recent Findings

Several factors influence the selection of treatment for BCC, including the histopathologic subtype, tumor depth, the presence of pigmentation or ulceration, the anatomic site, and patient’s physical profile. Dermoscopy was shown to provide additional information to the naked eye examination about several of these parameters and, therefore, might be very helpful tool in the pre-operative and post-treatment evaluation of BCCs.

Summary

In addition to its well-documented value in diagnosis, dermoscopy also gains ground in management of BCC. By revealing features not clinically seen, dermoscopy is a useful guide that enhances the selection of the appropriate treatment strategy and the assessment of post-treatment response.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. • Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167–79. This review article provides a thorough description of the pathogenetic, epidemiologic, clino-histopathologic features as well as the management options of BCC .

    PubMed  PubMed Central  CAS  Google Scholar 

  2. • Bichakjian CK, Olencki T, Aasi SZ, et al. Basal cell skin cancer, Version 1.2016, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(5):574–97. This article provides recommendations and guidance for selecting the appropriate treatment choice of BCCs based on patient-, lesion-, and disease-specific factors .

    Article  PubMed  Google Scholar 

  3. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ. 2004;329(7468):705.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Griffiths RW, Suvarna SK, Stone J. Do basal cell carcinomas recur after complete conventional surgical excision? Br J Plast Surg. 2005;58(6):795–805.

    Article  PubMed  CAS  Google Scholar 

  5. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003;148(2):195–202.

    Article  PubMed  CAS  Google Scholar 

  6. Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2010;24:505–12.

    Article  PubMed  CAS  Google Scholar 

  7. Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications—actinic keratoses, Bowen’s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27(5):536–44.

    Article  PubMed  CAS  Google Scholar 

  8. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50(5):722–33.

    Article  PubMed  Google Scholar 

  9. Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy W, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol. 2000;136(8):1012–6.

    Article  PubMed  CAS  Google Scholar 

  10. Altamura D, Menzies SW, Argenziano G, Zalaudek I, Soyer HP, Sera F, et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol. 2010;62(1):67–75.

    Article  PubMed  Google Scholar 

  11. Pan Y, Chamberlain AJ, Bailey M, Chong AH, Haskett M, Kelly JW. Dermatoscopy aids in the diagnosis of the solitary red scaly patch or plaque-features distinguishing superficial basal cell carcinoma, intraepidermal carcinoma, and psoriasis. J Am Acad Dermatol. 2008;59(2):268–74.

    Article  PubMed  Google Scholar 

  12. Lallas A, Apalla Z, Argenziano G, Longo C, Moscarella E, Specchio F, et al. The dermatoscopic universe of basal cell carcinoma. Dermatol Pract Concept. 2014;4(3):11–24.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lallas A, Argenziano G, Zendri E, Moscarella E, Longo C, Grenzi L, et al. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013;13(5):541–58.

    Article  PubMed  CAS  Google Scholar 

  14. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.

    Article  PubMed  CAS  Google Scholar 

  15. Reggiani C, Zalaudek I, Piana S, Longo C, Argenziano G, Lallas A, et al. Fibroepithelioma of pinkus: case reports and review of the literature. Dermatology. 2013;226(3):207–11.

    Article  PubMed  Google Scholar 

  16. Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol. 2009;60(1):137–43.

    Article  PubMed  Google Scholar 

  17. Giacomel J, Lallas A, Argenziano G, Reggiani C, Piana S, Apalla Z, et al. Dermoscopy of basosquamous carcinoma. Br J Dermatol. 2013;169(2):358–64.

    Article  PubMed  CAS  Google Scholar 

  18. Demirtaşoglu M, İlknur T, Lebe B, et al. Evaluation of dermoscopic and histopathologic features and their correlations in pigmented basal cell carcinomas. J Eur Acad Dermatol Venereol. 2006;20:916–20.

    Article  PubMed  Google Scholar 

  19. Tabanlıoğlu Onan D, Şahin S, Gököz Ö, Erkin G, Çakır B, Elçin G, et al. Correlation between the dermatoscopic and histopathological features of pigmented basal cell carcinoma. J Eur Acad Dermatol Venereol. 2010;24:1317–25.

    Article  PubMed  Google Scholar 

  20. • Lallas A, Tzellos T, Kyrgidis A, Apalla Z, Zalaudek I, Karatolias A, et al. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014;70(2):303–11. This diagnostic accuracy study evaluated the dermoscopic criteria associated with different BCC subtypes.

    Article  PubMed  Google Scholar 

  21. Longo C, Lallas A, Kyrgidis A, Rabinovitz H, Moscarella E, Ciardo S, et al. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy. J Am Acad Dermatol. 2014;71(4):716–724.e1.

    Article  PubMed  Google Scholar 

  22. Themstrup L, De Carvalho N, Nielsen SM et al. In vivo differentiation of common basal cell carcinoma subtypes by microvascular and structural imaging using dynamic optical coherence tomography. Exp Dermatol 2017

  23. Savoia P, Deboli T, Previgliano A, Broganelli P. Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma. Int J Mol Sci. 2015;16:23300–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Stebbins WG, Hanke CW. MAL-PDT for difficult to treat nonmelanoma skin cancer. Dermatol Ther. 2011;24:82–93.

    Article  PubMed  Google Scholar 

  25. Fantini F, Greco A, Del Giovane C, et al. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol. 2011;25:896–901.

    Article  PubMed  CAS  Google Scholar 

  26. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149:1242–9.

    Article  PubMed  CAS  Google Scholar 

  27. Arits AHHM, Mosterd K, Essers BAB, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14:647–54.

    Article  PubMed  CAS  Google Scholar 

  28. Apalla Z, Lallas A, Sotiriou E, Ioannides D. Effect of pigmentation on photodynamic therapy. Lancet Oncol. 2013;14:e339–40.

    Article  PubMed  Google Scholar 

  29. Tan W-P, Tan AW-H, Ee H-L, Kumarasinghe P, Tan SH. Melanization in basal cell carcinomas: microscopic characterization of clinically pigmented and non-pigmented tumours. Australas J Dermatol. 2008;49:202–6.

    Article  PubMed  Google Scholar 

  30. Lallas A, Argenziano G, Kyrgidis A, Apalla Z, Moscarella E, Longo C, et al. Dermoscopy uncovers clinically undetectable pigmentation in basal cell carcinoma. Br J Dermatol. 2014;170(1):192–5.

    Article  PubMed  CAS  Google Scholar 

  31. Urech M, Kyrgidis A, Argenziano G, Reggiani C, Moscarella E, Longo C, et al. Dermoscopic ulceration is a predictor of basal cell carcinoma response to imiquimod: a retrospective study. Acta Derm Venereol. 2017;97(1):117–9.

    Article  PubMed  Google Scholar 

  32. Peris K, Ferrari A, Fargnoli MC, et al. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma. Dermatol Surg. 2005;31:217–20.

    Article  PubMed  CAS  Google Scholar 

  33. Micantonio T, Fargnoli MC, Piccolo D, Letter PK. Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatol Surg. 2007;33:1403–5.

    PubMed  CAS  Google Scholar 

  34. Cuellar F, Vilalta A, Puig S, et al. Dermoscopy of early recurrent basal cell carcinoma. Arch Dermatol. 2008;144:1254.

    Article  PubMed  Google Scholar 

  35. Diluvio L, Campione E, Paterno EJ, et al. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face. J Dermatol Treat. 2009;20:124–9.

    Article  Google Scholar 

  36. Fargnoli MC, Kostaki D, Piccioni A, et al. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol. 2012;22:456–63.

    PubMed  Google Scholar 

  37. Husein-ElAhmed H, Fernandez-Pugnaire MA. Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod. An Bras Dermatol. 2016;91(6):764–9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. • Apalla Z, Lallas A, Tzellos T, Sidiropoulos T, Lefaki I, Trakatelli M, et al. Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. Br J Dermatol. 2014;170(4):809–15. This study suggests the utility of dermoscopy in the evaluation of treatment response and monitoring of sBCCs after nonablative therapies

    Article  PubMed  CAS  Google Scholar 

  39. Ally MS, Aasi S, Wysong A, et al. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. J Am Acad Dermatol. 2014;71(5):904–11.

    Article  PubMed  CAS  Google Scholar 

  40. Kwon GP, Ally MS, Bailey-Healy I, Oro AE, Kim J, Chang AL, et al. Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC). J Am Acad Dermatol. 2016;75(1):213–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aimilios Lallas.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Skin Cancer

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Papageorgiou, C., Apalla, Z., Vakirlis, E. et al. Use of Dermoscopy to Diagnose and Select BCCs that can be Treated Empirically. Curr Derm Rep 7, 84–90 (2018). https://doi.org/10.1007/s13671-018-0215-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-018-0215-z

Keywords

  • Basal cell carcinoma
  • Dermoscopy
  • Management
  • Treatment
  • Non-ablative therapies